uric acid has been researched along with ST Elevated Myocardial Infarction in 16 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Serum uric acid to albumin ratio (UAR) is a novel marker, which is associated with acute kidney injury in intensive care unit patients." | 8.31 | Serum Uric Acid to Albumin Ratio Can Predict Contrast-Induced Nephropathy in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention. ( Akbulut, T; Çınar, T; Şaylık, F; Selçuk, M, 2023) |
| "The goal of this investigation was to explore the relationship between serum uric acid/albumin ratio (UAR) and no-reflow (NR) in ST elevation myocardial infarction (STEMI) patients (n = 838) who underwent primary percutaneous coronary intervention (pPCI)." | 8.31 | The Association of Serum Uric Acid/Albumin Ratio with No-Reflow in Patients with ST Elevation Myocardial Infarction. ( Asal, S; Çiçek, V; Çınar, T; Hayıroğlu, Mİ; Şaylık, F; Selçuk, M; Tanboğa, İH, 2023) |
| "There is a lack of studies supporting the association between the uric acid/albumin ratio (UAR) and the development of new-onset atrial fibrillation (NOAF) in ST-elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (pPCI)." | 8.12 | Predictive value of uric acid/albumin ratio for the prediction of new-onset atrial fibrillation in patients with ST-Elevation myocardial infarction. ( Akbulut, T; Asal, S; Çiçek, V; Çınar, T; Hayıroğlu, Mİ; Şaylık, F; Selçuk, M; Tanboğa, İH, 2022) |
| "This disorder is correlated to a systemic inflammatory response and some biochemical factors." | 5.91 | C-reactive protein and uric acid roles in distinguishing ST-segment elevation myocardial infarction from non-ST-elevation acute coronary syndrome. ( Ghadakkar, N; Golabchi, A; Motedayyen, H; Zamani, B, 2023) |
| " Serum uric acid to albumin ratio (UAR) is a novel marker, which is associated with acute kidney injury in intensive care unit patients." | 4.31 | Serum Uric Acid to Albumin Ratio Can Predict Contrast-Induced Nephropathy in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention. ( Akbulut, T; Çınar, T; Şaylık, F; Selçuk, M, 2023) |
| "The goal of this investigation was to explore the relationship between serum uric acid/albumin ratio (UAR) and no-reflow (NR) in ST elevation myocardial infarction (STEMI) patients (n = 838) who underwent primary percutaneous coronary intervention (pPCI)." | 4.31 | The Association of Serum Uric Acid/Albumin Ratio with No-Reflow in Patients with ST Elevation Myocardial Infarction. ( Asal, S; Çiçek, V; Çınar, T; Hayıroğlu, Mİ; Şaylık, F; Selçuk, M; Tanboğa, İH, 2023) |
| "There is a lack of studies supporting the association between the uric acid/albumin ratio (UAR) and the development of new-onset atrial fibrillation (NOAF) in ST-elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (pPCI)." | 4.12 | Predictive value of uric acid/albumin ratio for the prediction of new-onset atrial fibrillation in patients with ST-Elevation myocardial infarction. ( Akbulut, T; Asal, S; Çiçek, V; Çınar, T; Hayıroğlu, Mİ; Şaylık, F; Selçuk, M; Tanboğa, İH, 2022) |
| " Hyperuricemia was defined as a serum uric acid level >7 mg/dL for males and >6 mg/dL for females." | 4.12 | Interaction between Hyperuricemia and Admission Lactate Increases the Risk of Acute Kidney Injury in Patients with ST-Segment Elevation Myocardial Infarction. ( He, Y; Hong, X; Huang, W; Liang, D; Lin, Q; Shan, P; Wang, D; Zhou, X; Zhu, Q, 2022) |
| "A total of 101 (86." | 2.87 | Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. ( Crimi, G; De Ferrari, GM; De Servi, S; Ferlini, M; Ferrario, M; Gianni, U; Leonardi, S; Mandurino-Mirizzi, A; Marinoni, B; Oltrona Visconti, L; Pica, S; Raineri, C; Repetto, A; Ruffinazzi, M, 2018) |
| "This disorder is correlated to a systemic inflammatory response and some biochemical factors." | 1.91 | C-reactive protein and uric acid roles in distinguishing ST-segment elevation myocardial infarction from non-ST-elevation acute coronary syndrome. ( Ghadakkar, N; Golabchi, A; Motedayyen, H; Zamani, B, 2023) |
| "In the 2369 patients with STEMI considered, 30-day mortality was 5." | 1.62 | Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. ( Camporotondo, R; Cornara, S; Crimi, G; De Ferrari, GM; Demarchi, A; Ferlini, M; Ferrario, M; Galazzi, M; Gnecchi, M; Mandurino-Mirizzi, A; Montalto, C; Oltrona-Visconti, L; Puccio, S; Somaschini, A, 2021) |
| "We analyzed 951 consecutive STEMI patients between February 2006 and September 2012." | 1.46 | Relationship of serum uric acid and Killip class on mortality after acute ST-segment elevation myocardial infarction and primary percutaneous coronary intervention. ( Chen, KC; Chiu, YW; Ke, SR; Liao, PC; Liu, CW; Liu, YH; Wu, YW, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 14 (87.50) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, X | 1 |
| Yang, X | 1 |
| Li, X | 1 |
| Li, G | 1 |
| Zhou, Y | 1 |
| Dong, H | 1 |
| Kalkan, S | 1 |
| Cagan Efe, S | 1 |
| Karagöz, A | 1 |
| Zeren, G | 1 |
| Yılmaz, MF | 1 |
| Şimşek, B | 1 |
| Batgerel, U | 1 |
| Özkalaycı, F | 1 |
| Tanboğa, İH | 3 |
| Oduncu, V | 1 |
| Karabay, CY | 1 |
| Kırma, C | 1 |
| Şaylık, F | 3 |
| Çınar, T | 3 |
| Akbulut, T | 2 |
| Selçuk, M | 3 |
| Kajana, V | 2 |
| Massaro, G | 1 |
| Somaschini, A | 4 |
| Cornara, S | 4 |
| Demarchi, A | 4 |
| Nardella, E | 1 |
| Nicoletti, A | 1 |
| Sangiorgi, GM | 1 |
| Mandurino-Mirizzi, A | 5 |
| Hayıroğlu, Mİ | 2 |
| Asal, S | 2 |
| Çiçek, V | 2 |
| He, Y | 1 |
| Wang, D | 1 |
| Zhou, X | 1 |
| Zhu, Q | 1 |
| Lin, Q | 1 |
| Hong, X | 1 |
| Huang, W | 1 |
| Shan, P | 1 |
| Liang, D | 1 |
| Zamani, B | 1 |
| Golabchi, A | 1 |
| Ghadakkar, N | 1 |
| Motedayyen, H | 1 |
| Badianyama, M | 1 |
| Mutyaba, A | 1 |
| Nel, S | 1 |
| Tsabedze, N | 1 |
| Çanga, Y | 1 |
| Emre, A | 1 |
| Karataş, MB | 1 |
| Çalık, AN | 1 |
| Yelgeç, NS | 1 |
| İnan, D | 1 |
| Yüksel, G | 1 |
| Terzi, S | 1 |
| Ruffinazzi, M | 2 |
| Crimi, G | 4 |
| Ferlini, M | 4 |
| Camporotondo, R | 3 |
| Gnecchi, M | 3 |
| Ferrario, M | 4 |
| Oltrona Visconti, L | 2 |
| De Ferrari, GM | 4 |
| Guo, W | 1 |
| Song, F | 1 |
| Chen, S | 1 |
| Zhang, L | 1 |
| Sun, G | 1 |
| Liu, J | 1 |
| Chen, J | 1 |
| Liu, Y | 1 |
| Tan, N | 1 |
| Galazzi, M | 2 |
| Puccio, S | 1 |
| Montalto, C | 1 |
| Oltrona-Visconti, L | 2 |
| Raineri, C | 1 |
| Pica, S | 1 |
| Gianni, U | 1 |
| Repetto, A | 1 |
| Marinoni, B | 1 |
| Leonardi, S | 1 |
| De Servi, S | 1 |
| Liu, CW | 1 |
| Liao, PC | 1 |
| Chen, KC | 1 |
| Chiu, YW | 1 |
| Liu, YH | 1 |
| Ke, SR | 1 |
| Wu, YW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Secretoneurin as a Biomarker of Atrial Fibrillation rEcurrence After Catheter Ablation/Electrical Cardioversion[NCT05794464] | 60 participants (Anticipated) | Interventional | 2023-05-01 | Recruiting | |||
| Aggressive Hydration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention to Prevent Contrast-Induced Nephropathy, A Randomized, Controlled Trial REduction of riSk of Contrast-Induced Nephropathy follow[NCT02067195] | 560 participants (Anticipated) | Interventional | 2014-07-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for uric acid and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Serum uric acid in patients with ST-segment elevation myocardial infarction: An innocent bystander or leading actor?
Topics: Humans; Myocardial Infarction; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarctio | 2022 |
2 trials available for uric acid and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
The relationship between hyperuricemia and contrast-induced acute kidney injury undergoing primary percutaneous coronary intervention: secondary analysis protocol for the ATTEMPT RESCIND-1 study.
Topics: Acute Kidney Injury; China; Contrast Media; Creatinine; Humans; Hyperuricemia; Logistic Models; Mult | 2020 |
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Aged; Angiography; Female; Humans; Kaplan-Meier Estimate; Linear Models; Magnetic Resonance Imaging; | 2018 |
13 other studies available for uric acid and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Elevated uric acid is related to the no-/slow-reflow phenomenon in STEMI undergoing primary PCI.
Topics: Aged; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Retrospective Studies; | 2022 |
A New Predictor of Mortality in ST-Elevation Myocardial Infarction: The Uric Acid Albumin Ratio.
Topics: Aged; Albumins; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Proportional | 2022 |
Serum Uric Acid to Albumin Ratio Can Predict Contrast-Induced Nephropathy in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.
Topics: Acute Kidney Injury; Albumins; Contrast Media; Creatinine; Humans; Kidney Diseases; Myocardial Infar | 2023 |
The Association of Serum Uric Acid/Albumin Ratio with No-Reflow in Patients with ST Elevation Myocardial Infarction.
Topics: Albumins; Coronary Angiography; Humans; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Pr | 2023 |
Predictive value of uric acid/albumin ratio for the prediction of new-onset atrial fibrillation in patients with ST-Elevation myocardial infarction.
Topics: Atrial Fibrillation; C-Reactive Protein; Cross-Sectional Studies; Humans; Retrospective Studies; Ris | 2022 |
Interaction between Hyperuricemia and Admission Lactate Increases the Risk of Acute Kidney Injury in Patients with ST-Segment Elevation Myocardial Infarction.
Topics: Acute Kidney Injury; Female; Humans; Hyperuricemia; Lactic Acid; Male; Risk Factors; ST Elevation My | 2022 |
C-reactive protein and uric acid roles in distinguishing ST-segment elevation myocardial infarction from non-ST-elevation acute coronary syndrome.
Topics: Acute Coronary Syndrome; C-Reactive Protein; Humans; ST Elevation Myocardial Infarction; Uric Acid | 2023 |
ST-segment elevation myocardial infarction heart of Charlotte one-year (STEMI HOC-1) study: a prospective study protocol.
Topics: Humans; Percutaneous Coronary Intervention; Prospective Studies; Risk Factors; South Africa; ST Elev | 2023 |
Prognostic value of serum uric acid levels in patients with non-STEMI undergoing percutaneous coronary intervention.
Topics: Adult; Female; Humans; Male; Percutaneous Coronary Intervention; Prognosis; Retrospective Studies; S | 2020 |
Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
Topics: Aged; Biomarkers; C-Reactive Protein; Female; Humans; Inflammation; Inflammation Mediators; Interleu | 2020 |
Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Aged; Biomarkers; C-Reactive Protein; Female; Humans; Hyperuricemia; Inflammation; Inflammation Medi | 2021 |
Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Creatinine; Female; Humans; Hyperuricemia; Ma | 2021 |
Relationship of serum uric acid and Killip class on mortality after acute ST-segment elevation myocardial infarction and primary percutaneous coronary intervention.
Topics: Aged; Biomarkers; Female; Humans; Male; Middle Aged; Mortality; Percutaneous Coronary Intervention; | 2017 |